Conference details: 18 & 19 May 2015, Holiday Inn Bloomsbury, London, UK.
Reviewing current opportunities in the effective and safe management of pain at SMi’s Pain Therapeutics conference.
SMi’s Pain Therapeutics conference returns to London on the 18th & 19th May 2015 with a two day intensive agenda highlighting the latest developments in pain therapeutics and offering attendees a unique platform to engage with KOLs and esteemed academia to learn the challenges and successes in the field of pain management.
With the increasing demand for new research techniques and a range of drugs to combat chronic pain syndromes, this conference will highlight key factors including personalised medicine for pain, biomarkers and CGRP receptor antagonists for migraine treatment. Attendees will learn about Grunenthal’s latest screening approach for neuropathic pain and pain models and hear timely case studies from Merck and Afferent Pharmaceuticals along with latest updates on developments in targeting nerve growth factors and advances in the treatment of pain from leading, pharma, biotech and academic experts from the industry. The conference will also feature an interactive panel discussion on reviewing validity of animal models for chronic pain.
Expert panel of speakers will include Dr Gregor Bahrenberg, Associate Scientific Director from Grunenthal, who will speak on Vesicular Glutamate Transporters (VGLUTs) as targets for neuropathic pain. Professor Alexander Oksche, Executive Director of Pharmacological Intelligence from Mundipharma will speak on day one, highlighting recent developments in opiods.
The conference will also feature a spotlight session on Nerve Growth (NGF) updates; Mark T Brown, MD, Executive Director, Tanezumab Clinical Program Leader for Osteoarthritis and Cancer Pain Studies, from Pfizer will speak on Update on Tanezumab, a monoclonal antibody inhibitor of nerve growth factor.
Delegates can also choose between two half day workshops, both held on 20th May 2015 in London: workshop A is on: In vitro techniques and models for pain drug development: “Clinical trial in a dish” in association with Imperial College London and workshop B is on: Healthcare Innovation – A patient centred approach, in association with Insight Consultancy.
ACNR 2014;15(1):38. Online 15/04/15